In this study, we sought to apply QTA analysis to molecularly defined NSCLC tumors to determine if noninvasively we could discriminate K-ras mutant from pan-wildtype cases and also determine if QTA could be used as a prognostic tool in early-stage NSCLC. Here, KRAS is linked to non-small cell lung carcinoma.